Genetics & Environmental Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics & Environmental Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Autoimmune Disease
A Life Sciences Renaissance: 100th Peer-Reviewed Publication Enabled by 454 Sequencing(TM)
November 22nd, 2007
454 Life Sciences, a Roche company, announced the publication of over 100 peer-reviewed studies using the Company's Genome Sequencer System. The studies span a diverse group of DNA sequencing applications, including de novo sequencing and re-sequencing of whole genomes, metagenomics, RNA analysis, and targeted sequencing of DNA regions of interest. The Genome Sequencer System, powered by 454 Sequencing, enables researchers to tackle innovative research, publish faster, and access diverse applications. 454 Sequencing's unique feature set of long reads, exceptional accuracy, and ultra-high throughput has enabled groundbreaking research, as evidenced by the large number of...
Source: Genetics & Environmental Business Week (2007-11-22)
|
